Article
Alarming levels of fluoroquinolone resistance among MDR-TB patients in Poland: molecular and phenotypic analysis.
Frontiers in cellular and infection microbiology - 1 Jan 2026
Kozińska Monika, Głogowska Agnieszka, Minias Alina, Dziadek Jarosław, Augustynowicz-Kopeć Ewa
Abstract excerpt
Background: Fluoroquinolones (FQs) are a cornerstone of modern multidrug-resistant tuberculosis (MDR-TB) treatment, particularly within the WHO-recommended all-oral BPaLM regimen. The emergence of FQ-resistant Mycobacterium tuberculosis (MTB) poses a critical threat to these life-saving therapies. While the global proportion of FQ resistance among MDR/RR-TB cases is estimated at 19%, phenotypic and molecular data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
